You are here:

Archived: fosamprenavir (Telzir)

Advice

In the absence of a submission from the holder of the marketing authorisation.

fosamprenavir (Telzir) in combination with low dose ritonavir is not recommended for use within NHSScotland for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adolescents and children of 6 years and above in combination with other antiretroviral medicinal products.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: fosamprenavir (Telzir)
SMC Drug ID: 431/07
Manufacturer: GlaxoSmithKline UK Ltd
Indication: for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adolescents and children of 6 years and above in combination with other antiretroviral medicinal products
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 December 2007

Current Advice

Abbreviated Submission 7 September 2009

Back